CAMPAGNA, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 2.824
AS - Asia 2.324
EU - Europa 1.686
SA - Sud America 338
AF - Africa 282
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.461
Nazione #
US - Stati Uniti d'America 2.728
CN - Cina 974
SG - Singapore 828
RU - Federazione Russa 624
IT - Italia 525
BR - Brasile 278
IE - Irlanda 181
VN - Vietnam 171
CI - Costa d'Avorio 156
KR - Corea 140
FR - Francia 84
CA - Canada 73
GB - Regno Unito 60
IN - India 60
NG - Nigeria 46
UA - Ucraina 45
NL - Olanda 35
BD - Bangladesh 25
ZA - Sudafrica 25
FI - Finlandia 24
PL - Polonia 24
DE - Germania 23
HK - Hong Kong 21
AR - Argentina 19
JP - Giappone 18
TR - Turchia 17
BJ - Benin 16
MX - Messico 15
IQ - Iraq 12
SE - Svezia 12
UZ - Uzbekistan 12
SN - Senegal 11
BE - Belgio 10
EC - Ecuador 10
MA - Marocco 10
CL - Cile 8
ES - Italia 8
KE - Kenya 8
PK - Pakistan 8
SA - Arabia Saudita 7
AT - Austria 6
AU - Australia 6
PE - Perù 6
VE - Venezuela 6
CH - Svizzera 5
CO - Colombia 5
HR - Croazia 4
ID - Indonesia 4
JO - Giordania 4
PH - Filippine 4
PY - Paraguay 4
ET - Etiopia 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KW - Kuwait 2
LB - Libano 2
QA - Qatar 2
SI - Slovenia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZM - Zambia 1
Totale 7.461
Città #
Dallas 648
Singapore 516
Santa Clara 480
Shenzhen 429
Moscow 272
Hefei 217
Dublin 180
San Jose 179
Ashburn 171
Chicago 160
Abidjan 156
Seoul 140
Catania 117
Chandler 105
Los Angeles 89
Boardman 79
Beijing 72
Lauterbourg 64
Jacksonville 58
Ho Chi Minh City 55
Palermo 44
Civitanova Marche 37
Andover 36
Council Bluffs 36
Lawrence 36
Cambridge 35
Hanoi 33
Nanjing 33
São Paulo 33
Toronto 32
Milan 28
New York 27
Buffalo 23
Montreal 23
Abuja 21
London 21
Orem 21
Bari 19
Des Moines 19
Lagos 19
Amsterdam 18
Warsaw 18
Lappeenranta 17
Cotonou 16
Denver 16
Johannesburg 15
Kochi 15
Brooklyn 14
Tokyo 14
Wilmington 14
Chennai 13
Hong Kong 13
San Giovanni la Punta 13
Rome 12
Dakar 11
Phoenix 11
Rio de Janeiro 11
Brussels 9
Jiaxing 9
Stockholm 9
Tashkent 9
Saint Petersburg 8
Washington 8
Biên Hòa 7
Boston 7
Da Nang 7
Dhaka 7
Mascalucia 7
Ottawa 7
Pune 7
San Francisco 7
The Dalles 7
Aci Castello 6
Baghdad 6
Belo Horizonte 6
Haiphong 6
Hebei 6
Houston 6
Leinfelden-echterdingen 6
Nanchang 6
Naples 6
Port Harcourt 6
Seattle 6
Tianjin 6
Brasília 5
Columbus 5
Dong Ket 5
Goiânia 5
Guayaquil 5
Lima 5
Manchester 5
Marseille 5
Mexico City 5
Mumbai 5
Nairobi 5
Santa Caterina Villarmosa 5
Sydney 5
Aci Catena 4
Ankara 4
Buenos Aires 4
Totale 5.268
Nome #
EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study 541
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 204
A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol 203
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 190
Comment on Elsayed et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S68–S96 176
Comparing the Effectiveness, Tolerability, and Acceptability of Heated Tobacco Products and Refillable Electronic Cigarettes for Cigarette Substitution (CEASEFIRE): Randomized Controlled Trial 174
A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study protocol 160
"Dangerous relationships": asthma and substance abuse 160
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 156
Changes in breathomics from a 1-year randomised smoking cessation trial of electronic cigarettes 153
An uncommon cause of syncope 135
Smoking and diabetes: Dangerous liaisons and confusing relationships 133
Counseling patients with asthma and allergy about electronic cigarettes: an evidence-based approach 129
Assessment and repeatability of aerobic capacity using the Chester Step Test among current, former, and never smokers 127
Rare benign tumors of the liver: still rare? 127
Behavioral Therapy for People With Diabetes Who Smoke: A Scoping Review 125
A computational framework for complex disease stratification from multiple large-scale datasets 124
Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis 124
Varenicline for smoking cessation in individuals who smoke cigarettes and use electronic cigarettes: a double-blind, randomised, placebo-controlled phase 3 trial 122
ON-TREATMENT SERUM HBsAG DECLINE DURING TELBIVUDINE THERAPY IN NAÏVE CHRONIC HEPATITIS B: CASE REPORT 118
Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial 116
Distance follow-up by a remote medical care centre improves adherence to CPAP in patients with obstructive sleep apnoea over the short and long term 115
Evaluation of Post Cessation Weight Gain in a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes 114
Correction: Smoking and diabetes: dangerous liaisons and confusing relationships 113
COVID-19 and emergency departments: need for a validated severity illness score. The history of emerging CovHos score 112
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial 108
Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study 105
Diabete, tabagismo e disassuefazione dal fumo 97
Tobacco Smoking or Nicotine Phenotype and Severity of Clinical Presentation at the Emergency Department (SMOPHED): Protocol for a Noninterventional Observational Study 94
A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness 93
The Impact of Tobacco Cigarettes, Vaping Products and Tobacco Heating Products on Oxidative Stress 91
COMPLICATION AND HOSPITALISATION AFTER PERCUTANEOUS LIVER BIOPSY: A COHORT STUDY OF 12 YARS 91
Combination therapy with pegylated-Interferon and Ribavirin determines a decrease in Squamous Cell Carcinoma Antigen (SCCA)-Immunoglobulin M (IgM) complex (SCCA-IgM IC) serum levels in patients with HCV-related liver cirrhosis 87
Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes 87
URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME 86
THE EFFICACY AND SAFETY OF AN ELECTRONIC CIGARETTE (ECLAT) STUDY: A PROSPECTIVE 12-MONTH RANDOMIZED CONTROL DESIGN STUDY. 85
Influence of quitting smoking on diabetes-related complications: A scoping review with a systematic search strategy 84
International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: The DIASMOKE protocol 84
SAFETY AND EFFICACY OF LOW DOSAGE OF FONDAPARINUX IN CIRRHOTIC PATIENTS WITH PORTAL VEIN THROMBOSIS 83
Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes 82
Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes 82
URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITHNONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME 81
Protocol for the "magnitude of cigarette substitution after initiation of e-cigarettes and its impact on biomarkers of exposure and potential harm in dual users" (MAGNIFICAT) study 80
Smoking habits predict adverse effects after mRNA COVID-19 vaccine: Empirical evidence from a pilot study 79
EFFETTO DI UN INALATORE SENZA NICOTINA ALL’INTERNO DI UN PROGRAMMA DI DISUASSEFAZIONE DAL FUMO DI SIGARETTA 78
IL-17-high asthma with features of a psoriasis immunophenotype 75
Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence 74
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? 73
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? Reply 73
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-negative chronic hepatitis B patients 73
Respiratory infections and pneumonia: potential benefits of switching from smoking to vaping 73
Effect of a nicotine-free inhalator as part of a smoking-cessation programme 72
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 72
Impact of air quality on lung health: myth or reality? 72
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux 72
THE COMPARATIVE STUDY OF TERLIPRESSIN AND ALBUMIN FOR TYPE-1 HEPATORENAL SYNDROME (HRS) IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL PERITONITIS (SBP) VS CIRRHOSIS ALONE 71
The emerging phenomenon of electronic cigarettes 70
Persisting Long Term Benefits of Smoking Abstinence and Reduction in Asthmatic Smokers Who Have Switched to Electronic Cigarettes 69
Relationship between tobacco and nicotine products use and clinical presentation at the Emergency Department: study protocol 68
Different death rates between COVID-19 waves among unvaccinated patients: moving beyond lessons learned 68
Taking for Granted Conclusions from Studies that Cannot Prove Causality of Respiratory Symptoms and Vaping 67
Effect of an electronic cigarette on smoking cessation and reduction: A prospective pilot study 67
Stratification of asthma phenotypes by airway proteomic signatures 67
Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series 65
Sustained Virological Response reduces insulin resistance in patients with genotype 1 Chronic Hepatitis C 65
Smoking Cessation with E-Cigarettes in Smokers with a Documented History of Depression and Recurring Relapses 63
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study 59
THE EFFICACY AND SAFETY OF AN ELECTRONIC CIGARETTE (ECLAT) STUDY: A PROSPECTIVE 12-MONTH RANDOMIZED CONTROL DESIGN STUDY. 59
Erratum: EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study (PLoS ONE (2014) 9:1 (DOI:10.1371/annotation/e12c22d3-a42b-455d-9100- 6c7ee45d58d0)) 56
Preventing asthma exacerbation in adults 52
Mechanistic toxicity profiling of nicotine-rich e-liquids: mitochondrial and oxidative stress responses in ALI-exposed bronchial cells 49
Faldaprevir for the treatment of hepatitis C 46
Subacute bronchial toxicity induced by an electronic cigarette: take home message 42
Differential Associations Between Smoking, E-Cigarette Use, and Diabetes Prevalence 27
Totale 7.567
Categoria #
all - tutte 22.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 5 14 10
2021/2022259 28 39 2 3 38 10 45 6 13 4 8 63
2022/2023480 39 25 11 21 27 58 30 73 130 9 34 23
2023/2024922 47 54 462 23 24 85 4 22 10 22 75 94
2024/20251.711 32 248 102 100 344 243 52 36 96 157 134 167
2025/20263.877 275 347 802 287 512 748 375 71 248 212 0 0
Totale 7.567